Search results (316)
« Back to Publicationsssessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.
Journal article
Cholesterol Treatment Trialists' (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk . and Cholesterol Treatment Trialists' (CTT) Collaboration ., (2026), Lancet
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trial.
Journal article
Bernholm KF. et al, (2026), Eur J Clin Microbiol Infect Dis
Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination Against Hospitalizations and Deaths According to Frailty Score: A Post Hoc Analysis of the DANFLU-1 Randomized Trial.
Journal article
Espersen C. et al, (2026), J Infect Dis, 233, e89 - e98
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.
Journal article
Nielsen AB. et al, (2026), JAMA Intern Med
pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial.
Journal article
Johansen ND. et al, (2026), Am Heart J, 291, 186 - 198
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group ., (2026), Lancet Infect Dis, 26, 34 - 45
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: The DANFLU-2 Trial Subgroup Analysis.
Journal article
Bartholdy KV. et al, (2025), J Am Coll Cardiol, 86, 2636 - 2647
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Atrial Fibrillation: A Prespecified Analysis of the DANFLU-2 Trial.
Journal article
Espersen C. et al, (2025), J Am Coll Cardiol, 86, 2651 - 2655
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.
Journal article
Johansen ND. et al, (2025), N Engl J Med, 393, 2291 - 2302
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Journal article
Zhu D. et al, (2025), Am J Kidney Dis
Discordance in Creatinine- and Cystatin C-Based eGFR and Clinical Outcomes: A Meta-Analysis.
Journal article
Estrella MM. et al, (2025), JAMA, 334, 1915 - 1926
Bayesian re-analysis of the DANFLU-1 trial.
Journal article
Modin D. et al, (2025), Hum Vaccin Immunother, 21
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis.
Journal article
Herrington WG. et al, (2025), Lancet Diabetes Endocrinol, 13, 1003 - 1014
High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial.
Journal article
Pareek M. et al, (2025), Eur Heart J, 46, 4282 - 4290
Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 Inhibition.
Journal article
Malijan GB. et al, (2025), Kidney Int Rep, 10, 4090 - 4093